CoChat

TGF-Beta: a Master Switch in Tumor Immunity

Gigante, Margherita, Gesualdo, Loreto, Ranieri, Elena · 2012 · Current Pharmaceutical Design

The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.

Abstract

The capacity of the immune system to distinguish foreign from self-antigen, and to subsequently eliminate the threat of disease without injuring the host is crucial for survival. It also serves to defend against tumor formation and progression via a process termed cancer immunosurveillance. Innate and adaptive immune cell types and effector molecules collectively function as extrinsic tumorsuppressor mechanisms. However, tumors may escape immunesurveillance through a variety of mechanisms that create a local microenvironment that is unfavorable for effective tumor immunity. Transforming growth factor β (TGF-β) has pleiotropic effects on the immune system, and is recognized as one of the most potent immunosuppressive agents in facilitating oncogenesis. The TGF-β pathway promotes cancer progression by concomitantly enhancing tumor metastases while inhibiting the protective host immunity. In this review, we discuss mechanisms through which TGF-β interferes with the development of an anti-tumor immunity and potential means through which to circumvent its activity in order to define more effective cancer immunotherapies.

Overview

Integrity signals

Registry

Crossref · 10.2174/138161212802430378

Cites

121 of 121 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 121 references

Cited by

See all 53

Metadata

Authors
Gigante, M., Gesualdo, L., & Ranieri, E.
Affiliations
University of Foggia (IT)
Venue
Current Pharmaceutical Design
Published
2012-09-01
Volume
18
Issue
27
Pages
4126-4134
ISSN
1381-6128 (ISSN-L)
OpenAlex
W2055370220
Cited by
45
References
121
Citations by year
2026: 2 · 2024: 3 · 2023: 1 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 7 · 2018: 4 · 2017: 6 · 2016: 2 · 2015: 4 · 2014: 1 · 2013: 5
FWCI
1.28
Type
journal article
Language
en
Open access
closed
Locations
  • Current Pharmaceutical Design (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
  • CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
TGF-beta, antitumor immunity, tumor surveillance, immunosuppression, tumor microenvironment, metastasis, cancer immunotherapy, immune evasion, carcinogenesis
MeSH terms
Animals, Humans, Immunity, Innate, Immunologic Surveillance, Neoplasm Metastasis, Neoplasms, Transforming Growth Factor beta, Disease Progression, Adaptive Immunity, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TGF-Beta: a Master Switch in Tumor Immunity. https://app.cochat.ai/papers/10.2174/138161212802430378
The paper
Gigante, M., Gesualdo, L., & Ranieri, E. (2012). TGF-Beta: a Master Switch in Tumor Immunity. Current Pharmaceutical Design. https://doi.org/10.2174/138161212802430378

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.